Dr. Ahmed Sedik | Pharmacology | Best Researcher Award

Dr. Ahmed Sedik | Pharmacology | Best Researcher Award

Dr. Ahmed Sedik, National research centre, Egypt

Dr. Ahmed Abdelfatah Abdallah Sedik πŸŽ“ is a dedicated researcher in pharmacology and neuroscience 🧠, currently serving as a Visiting Researcher at the Image & Connectomics in Clinical Neurosciences (ICCN) group, Clermont Auvergne INP, France πŸ‡«πŸ‡·. With a Ph.D. in Pharmacology πŸ₯Ό from Benha University, Egypt πŸ‡ͺπŸ‡¬, his expertise spans hepatic encephalopathy, metabolic disorders, and connectomics research. Dr. Sedik has made significant contributions to pharmacological science through innovative experiments and international collaborations 🌍. Passionate about education πŸ“˜, he has conducted various workshops and training courses for students. His accolades include the prestigious NRC Award and Fulbright Award πŸ†.

Professional Profile:

Orcid

Summary of Suitability for the Best Researcher Award

Ahmed Abdelfatah Abdallah Sedik is a strong candidate for the Best Researcher Award due to his extensive research experience, academic achievements, technical expertise, and impactful contributions to pharmacology and clinical neuroscience. His track record of international recognition, teaching and mentoring roles, and commitment to advancing knowledge and innovation place him among the most deserving for such a prestigious accolade.

Education and Experience 

Education πŸŽ“

  1. Postdoctoral Researcher: Image & Connectomics in Clinical Neurosciences, Clermont Auvergne INP, France (2024) 🌍
  2. Ph.D. in Pharmacology: Hepatic Encephalopathy in Rats, Benha University, Egypt (2020) πŸ§ͺ
  3. M.Sc. in Pharmacology: Insulin Resistance in Rats, Benha University, Egypt (2016) πŸ”¬
  4. B.V.Sc. in Veterinary Medicine: Very Good (B+), Benha University, Egypt (2011) 🐾

Experience πŸ§‘β€πŸ”¬

  1. Researcher, Pharmacology Department, National Research Centre (NRC), Egypt (2020–Present) 🧬
  2. Assistant Researcher, Pharmacology Department, NRC, Egypt (2016–2020) πŸ₯Ό
  3. Research Assistant, Pharmacology Department, NRC, Egypt (2014–2016) βš™οΈ
  4. Demonstrator, Pharmacology Department, NRC, Egypt (2013–2014) πŸ“Š

Professional Development 

Dr. Ahmed Sedik has actively pursued professional growth through numerous workshops and training programs πŸ› οΈ. His journey includes mastering statistical analysis πŸ“Š, enhancing publication skills ✍️, and refining oral presentation techniques 🎀. He has participated in global initiatives such as the Egyptian Knowledge Bank workshops πŸ“š and training programs by SIGMA Pharmaceuticals πŸ’Š. Hands-on sessions with advanced equipment like powerlab systems and labchart integration further underscore his commitment to interdisciplinary research βš—οΈ. Dr. Sedik also emphasizes capacity building for young researchers πŸ§‘β€πŸ« and stays updated with modern tools like EndNote for effective research management πŸ› οΈ.

Research Focus 

Dr. Sedik’s research explores cutting-edge topics in pharmacology πŸ§ͺ and neuroscience 🧠. His work spans hepatic encephalopathy, metabolic disorders 🩺, and innovative drug therapies πŸ’Š. At Clermont Auvergne INP, he investigates neuroimaging techniques πŸ“·, connectomics, and behavioral experiments πŸ€. His expertise includes handling experimental animals 🐁, molecular biology tools like PCR and Western blotting 🧬, and analytical methods such as FTIR and flow cytometry πŸ”¬. Dr. Sedik’s focus on experimental pharmacology and translational research bridges preclinical findings and therapeutic applications πŸš€. His dedication contributes to advancements in pharmacological interventions and neurotherapeutics 🌍.

Awards and Honors 

  1. πŸ† NRC Award: Best International Publishing (2017)
  2. 🌟 Fulbright Award: Best Innovative Scientific Project (2014)

Publication Top Notes:

 Novel drugs affecting diabetic peripheral neuropathy
Neuroprotective and cognitive enhancing effects of herbecetin against thioacetamide induced hepatic encephalopathy in rats via upregulation of AMPK and SIRT1 signaling pathways
Lauric acid attenuates hepato-metabolic complications and molecular alterations in high-fat diet-induced Non-alcoholic Fatty Liver Disease in rats
Mitigating effect of ferulic acid on di-(2-ethylhexyl) phthalate-induced neurocognitive dysfunction in male rats with a comprehensive in silico survey
Immunoregulatory role of hesperidin against ovalbumin (OVA)-induced bronchial asthma and depression in rats